Cefowin Injection 1000mg (Summary Report)
Cefowin Injection 1000mg (Summary Report)
SUMMARY REPORT
Product: CEFOWIN INJECTION 1000mg
TEST SPECIFICATIONS RESULTS
B.No. 007CV B.No. 044CV B.No. 036CV
Mfg.: 03-2019 Mfg.: 11-2019 Mfg.: 11-2019
Exp. : 03-2021 Exp. : 11-2021 Exp. : 11-2021
Appearance White to yellowish orange crystalline Almost white Almost white Almost white
powder. crystalline crystalline crystalline
powder. powder. powder.
Identification (HPLC) The retention time of the major peak of
Cefotaxime in the chromatogram of
Retention Retention Retention
assay preparation, corresponds to that
time Complies time Complies time Complies
exhibited in the chromatogram of the
standard preparation.
pH of solution 4.5 – 6.5 5.1 5.15 5.17
Constituted solution Complies with the test Complies Complies Complies
Particulate matter The solution is free from visible, un
Complies Complies Complies
dissolved foreign particles.
ASSAY Label Claim: Limit:
(Cefotaxime as 500mg/vial 90% - 115% 98.77% 99.22% 104.16%
sodium)
MICROBIAL TESTS
Sterility Meets the requirement of sterility test sterile sterile sterile
Bacterial Endotoxin NMT 0.2Eu/mg of ceftriaxone No gel No gel No gel
observed observed observed
(Label Claim: Cefotaxime as sodium = 1000mg/vial)